Haleon plc Q1 Trading Statement

Haleon plc announced its Q1 trading statement for the year ending December 31, 2026. The statement is available on the company's website and has been submitted to the Financial Conduct Authority. A presentation and Q&A session for analysts and shareholders will be hosted by the CEO and CFO on April 29, 2026. Dial-in details and an archived webcast will be provided. The company also provided contact information for investor and media relations. Haleon is a consumer company focused on everyday health with brands in oral health, VMS, pain relief, respiratory health, digestive health, and therapeutic skin health.